Skip to content

Randomised trial, 2017

Can chasteberry (Vitex agnus castus) help premenstrual breast pain and PMS?

Based on a review of earlier placebo-controlled studies, chasteberry extract seems to ease premenstrual breast pain and some PMS symptoms, likely by lowering prolactin. Side effects were mild and infrequent, but this is a summary of past research, not a new trial.

Early or limited evidence Women with premenstrual symptoms, breast pain, fibrocystic breast disease, or related infertility, across multiple earlier studies.

What they did

This is a review article, not a new experiment. It pulls together earlier placebo-controlled trials and lab research on chasteberry extract (mainly the preparation BNO 1095) for premenstrual syndrome, premenstrual breast pain (mastodynia), fibrocystic breast disease, and infertility linked to high prolactin.

What they found

Placebo-controlled studies cited in the review found chasteberry extract reduced premenstrual breast pain, and this was linked to lower blood prolactin levels. Compounds in the plant bind to dopamine D2 receptors, which reduces prolactin release; this was shown in pituitary cells, in rats, and in postmenopausal women. The extract also helped women with fibrocystic breast disease and premenstrual dysphoric disorder. Adverse effects were described as mild and generally infrequent.

What it means for you

Chasteberry extract may ease premenstrual breast pain and related symptoms, probably by lowering prolactin, but because this is a review summarizing older studies rather than new controlled data, it does not give specific sample sizes or effect sizes to check the strength of each underlying trial.

50

years chasteberry has been used for premenstrual symptoms

About the study

Original title
The premenstrual syndrome, premenstrual mastodynia, fibrocystic mastopathy and infertility have often common roots: effects of extracts of chasteberry (Vitex agnus castus) as a solution
Authors
Dana Seidlová‐Wuttke, W. Wuttke
Journal
Clinical Phytoscience
Year
2017
Study design
Randomised trial
What was tested
Chasteberry (Vitex agnus castus) extract, mainly the preparation BNO 1095, compared with placebo in the studies reviewed.
Open access
Yes
Original abstract

The dried fruits of the chaste tree Vitex agnus castus (VAC) were traditionally used by monks as a substitute for pepper and was therefore also called Monk’s pepper. For the last 50 years it is commercially provided for the treatment of premenstrual symptoms, particularly to prevent premenstrual mastodynia (mastalgia). Most studies were performed with the preparation containing an aqueous/ethanolic ectract BNO 1095. A number of placebo controlled studies gave proof that extracts of VAC had beneficial effects on premenstrual breast pain. This breast sensation is induced by latent hyperprolactinemia which is characterized by secretory episodes of prolactin release by the pituitary in response to stress and deep sleep phases. This latent hyperprolactinemia induces also often a corpus luteum insufficiency which is a common reason for infertilty. It is well accepted that prolactin release can be reduced by dopamine and dopaminergic drugs. The efficacy of VAC extracts to ameliorate prolactin induced premenstrual mastodynia was therefore suggestive that VAC may contain dopaminergic compounds. Indeed, a number of diterpenes were identified that bound to recombinant Dopamine receptors of the 2 subtype (D2 receptors) which are present in pituitary lactotropes and which mediate the inhibitory effects of dopamine and dopaminergic drugs on pituitary prolactin release. Consequently, prolactin release in vitro from dispersed pituitary cells and in vivo in rats and postmenopausal women was inhibited by VAC 1095. Placebo controlled studies proved also the efficacy of VAC extracts to ameliorate premenstrual symptoms. In several placebo-controlled studies a clear relation between reduction of breast pain and reduction of serum prolactin levels could be established. In addition VAC extracts was also highly effective in women suffering from fibrocystic mastopathy. In many of these women serum prolactin levels were also elevated and reduced by VAC extracts. The results from all trials suggested that VAC extracts ameliorated premenstrual symptoms including mastodynia, premenstrual dysphoric disorder and latent hyperprolactinemia. Cystic mastopathy and sterility due to corpus luteum insufficiencies were also beneficially influenced. Adverse events with VAC were mild and generally infrequent.

Reproduced under CC-BY.

Topics